The Value of Sensitivity Analyses in Assessing the Risk of Two Rare Neurological Adverse Events and Pseudoephedrine Use

G. Caleb Alexander (), Francine Chingcuanco, Abhilok Garg and Daniel Budnitz
Additional contact information
G. Caleb Alexander: Stage Analytics
Francine Chingcuanco: Stage Analytics
Abhilok Garg: Medical Affairs Europe, Middle East, and Africa
Daniel Budnitz: Product Vigilance and Safety System Oversight

Drug Safety, 2025, vol. 48, issue 10, No 1, 1073-1077

Date: 2025
References: Add references at CitEc
Citations:

Downloads: (external link)
http://link.springer.com/10.1007/s40264-025-01575-0 Abstract (text/html)
Access to the full text of the articles in this series is restricted.

Related works:
This item may be available elsewhere in EconPapers: Search for items with the same title.

Export reference: BibTeX RIS (EndNote, ProCite, RefMan) HTML/Text

Persistent link: https://EconPapers.repec.org/RePEc:spr:drugsa:v:48:y:2025:i:10:d:10.1007_s40264-025-01575-0

Ordering information: This journal article can be ordered from
http://www.springer.com/adis/journal/40264

DOI: 10.1007/s40264-025-01575-0

Access Statistics for this article

Drug Safety is currently edited by Nitin Joshi

More articles in Drug Safety from Springer
Bibliographic data for series maintained by Sonal Shukla () and Springer Nature Abstracting and Indexing ().